Bank of America’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10
Closed -$9 7061
2025
Q4
$9 Hold
10
﹤0.01% 7211
2025
Q3
$29 Sell
10
-5,138
-100% -$14.5K ﹤0.01% 8119
2025
Q2
$14.6K Buy
5,148
+5,097
+9,994% +$16.2K ﹤0.01% 7118
2025
Q1
$200 Sell
51
-1
-2% -$5 ﹤0.01% 7691
2024
Q4
$138 Buy
52
+4
+8% +$12 ﹤0.01% 7668
2024
Q3
$146 Buy
48
+44
+1,100% +$231 ﹤0.01% 7639
2024
Q2
$25 Buy
+4
New +$30 ﹤0.01% 7966
2023
Q1
Sell
-1
Closed -$8 8341
2022
Q4
$8 Buy
+1
New +$23 ﹤0.01% 8105

Other funds holding AIFF

Bank of America's AIFF Position: Q1 2026 in Review

Bank of America sold out of Firefly Neuroscience (AIFF) in Q1 2026, closing a stake of 10 shares — an estimated $9 sold.

Bank of America first reported a position in AIFF in Q4 2022 and held it in 8 quarters. The position peaked at $14.6K in Q2 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • Bank of America reported no remaining Firefly Neuroscience position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 10 Firefly Neuroscience shares in Q1 2026, an estimated $9.
  • Bank of America first reported a position in Firefly Neuroscience in Q4 2022 and held it in 8 quarters.
  • Bank of America's Firefly Neuroscience position peaked at $14.6K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.